Ironwood Pharmaceuticals, Inc. news

   Watch this stock
Showing stories 1 - 10 of about 60   

Articles published

IRWD 12.52 -0.39 (-3.02%)
price chart
Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) drug Linzess might not be ...
Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) closed its day at $13.49. The introductory price for the day was $13.41, during the day the stock jumped to hit its day high of $13.71 and fell to $13.16 during the day, while the average true range of the ...
Ironwood Pharma Prices $136.5 Mln Stock Offering  NASDAQ
Related articles »  
Ironwood Pharmaceuticals Inc. (IRWD) Is Falling After Offering Announcement
Ironwood Pharmaceuticals Inc. (IRWD: Quote) announced after the bell Monday that it has commenced an underwritten public offering of 10,500,000 shares of its Class A common stock.
Ironwood Pharmaceuticals Inc. (NASDAQ:IRWD) down by 4.30%, Astex ...
Ironwood Pharmaceuticals Inc. (NASDAQ:IRWD) closed its day at $12.91 after falling 4.30%, hit a high of $13.65 and a low of $12.65, the average true range of the stock is $0.67.
Related articles »  
NASDAQ Decliners Watch List: Xenoport, Inc. (NASDAQ:XNPT), Ironwood ...
New York, NY -- (SBWIRE) -- 05/21/2013 -- Growing Stock Report expands its NASDAQ Decliners Weekly Watch List adding Xenoport, Inc. (NASDAQ:XNPT), Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD), and The Spectranetics Corporation ...
Related articles »  
IRONWOOD PHARMACEUTICALS, INC. : Ironwood Pharmaceuticals ...
Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) today announced that it has commenced an underwritten public offering of 10,500,000 shares of its Class A common stock.
Ironwood Pharmaceuticals to raise $136M in stock offering
Ironwood Pharmaceuticals Inc. will close its public offering of 10.5 million shares of stock worth nearly $136.5 million tomorrow.
Ironwood Pharma Prices Stock Offering  Zacks.com
Ironwood to raise $136M to support launch of IBS treatment drug  Boston Business Journal (blog)
Related articles »  
IRONWOOD PHARMACEUTICALS, INC. : Ironwood Pharmaceuticals to Present ...
Ironwood Pharmaceuticals (NASDAQ: IRWD) is committed to the art and science of making medicines, from discovery through commercialization.
Ironwood Pharmaceuticals Downgraded to Neutral at Cowen Securities (IRWD)  Zolmax
Related articles »  
Ironwood Pharmaceuticals Inc (NASDAQ:IRWD) and Ariad Pharmaceuticals Inc ...
Ironwood Pharmaceuticals, Inc (NASDAQ:IRWD): In Thursday's trading session, Ironwood Pharmaceuticals, Inc (NASDAQ:IRWD) dropped 3.12%. Its opening price of $15.01 was also the intraday high, which eventually headed down to close at $14.60 per ...
Related articles »  
IDEXX Laboratories, Inc. (NASDAQ:IDXX), Ironwood Pharmaceuticals, Inc ...
Wilmington, DE -- (SBWIRE) -- 04/23/2013 -- Equity Profile Report expands its NASDAQ Decliners Weekly Watch List adding IDEXX Laboratories, Inc. (NASDAQ:IDXX), Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD), and Achillion Pharmaceuticals, Inc.
Related articles »  
NASDAQ Decliners Watch List: Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD ...
New York, NY -- (SBWIRE) -- 04/24/2013 -- Growing Stock Report expands its NASDAQ Decliners Weekly Watch List adding Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD), Cell Therapeutics, Inc. (NASDAQ:CTIC), and Exact Sciences Corporation ...
Related articles »